The role of the opioid pathway in schizophrenia and bipolar ...
Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.
Newsletters and Deep Dive digital magazine
Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.
Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.
Investor panic has poleaxed Quince Therapeutics share price, after a regulatory filing revealed the biotech's cash is running out.
Lundbeck seems to have brought its migraine prevention drug bocunebart back on track with positive data for an intravenous formulation.
This week's biofinancings include a nine-figure round for ILiAD, with Quantx Bio, Aerska, Galux, and Pandorum Technologies also raising new funds.
Editor's Picks
Newsletters and Deep Dive
digital magazine